Synephrine and Its Derivative Compound A: Common and Specific Biological Effects.

Area of Science:

• Pharmacology
• Natural Products Chemistry
• Molecular Biology

Background:

• Synephrine is a key phytochemical in bitter orange, utilized in dietary supplements for weight management.
• Its biological targets and mechanisms of action are crucial for understanding its effects.
• Selective glucocorticoid receptor agonists (SEGRAs) offer therapeutic benefits with fewer side effects than traditional glucocorticoids.

Purpose of the Study:

• To review the biology, molecular targets, and pharmacological properties of synephrine.
• To compare synephrine with its metabolite, Compound A (CpdA), a SEGRA.
• To explore synephrine's potential as a template for novel non-steroidal SEGRAs.

Main Methods:

• Literature review of synephrine's origin, chemistry, and pharmacology.
• Analysis of in vitro and animal studies on synephrine's anti-inflammatory and anti-cancer activities.
• Comparative assessment of synephrine and CpdA molecular targets and effects.

Main Results:

• Synephrine exhibits anti-inflammatory and anti-cancer properties in preclinical models.
• Synephrine shares structural similarities with SEGRA Compound A.
• Insights into synephrine's safe pharmacological profile are provided.

Conclusions:

• Synephrine possesses diverse pharmacological activities, including anti-inflammatory and anti-cancer effects.
• Synephrine serves as a potential scaffold for developing new non-steroidal SEGRAs.
• Further research into synephrine's therapeutic applications is warranted.